keyword
https://read.qxmd.com/read/38646419/renal-function-improvement-with-glucagon-like-peptide-1-receptor-agonist-in-a-patient-with-type-2-diabetes
#1
Hidekatsu Yanai
Diabetic kidney disease (DKD) includes hypertensive nephrosclerosis, aging, obesity, and atherosclerosis-related renal diseases, in addition to classical diabetic nephropathy. Sodium-glucose co-transporter 2 inhibitors (SGLT2is) have been approved for diabetic and non-diabetic patients at risk of chronic kidney disease progression. As the main mechanism for SGLT2i-mediated improvement of renal function, the normalization of tubulo-glomerular feedback (TGF) has been proposed. Enhanced TGF and resulting glomerular hypertension are observed in diabetic patients, and SGLT2is normalize TGF, reducing the intraglomerular pressure, which may reduce albuminuria and improve renal function...
April 2024: Journal of Medical Cases
https://read.qxmd.com/read/38646317/understanding-the-clinical-relationship-between-diabetic-retinopathy-nephropathy-and-neuropathy-a-comprehensive-review
#2
REVIEW
Aditi Kulkarni, Archana R Thool, Sachin Daigavane
Diabetic retinopathy, nephropathy, and neuropathy are significant microvascular complications of diabetes mellitus, contributing to substantial morbidity and mortality worldwide. This comprehensive review examines the clinical relationship between these complications, focusing on shared pathophysiological mechanisms, bidirectional relationships, and implications for patient management. The review highlights the importance of understanding the interconnected nature of diabetic complications and adopting a holistic approach to diabetes care...
March 2024: Curēus
https://read.qxmd.com/read/38646286/a-study-assessing-the-role-of-renal-grayscale-ultrasonography-and-flowmetry-in-correlation-with-renal-function-tests-across-various-renal-diseases
#3
JOURNAL ARTICLE
Yashaswinii Polaka, Evangeline P Christina, Karthik Krishna Ramakrishnan, Arunkumar Mohanakrishnan, Paarthipan Natarajan
Background Renal insufficiency, a critical concern in native and transplant kidneys, necessitates effective screening modalities for evaluation and management. Grayscale sonography has been a cornerstone in renal diagnostics, providing basic anatomical insights such as renal length, cortical thickness, and collecting system dilatation. Despite technological advancements, its impact on the differential diagnosis or management of renal disease remains limited, often showing normal findings in the presence of severe renal dysfunction...
March 2024: Curēus
https://read.qxmd.com/read/38646230/association-of-hypomagnesemia-with-diabetic-complications
#4
JOURNAL ARTICLE
Syed Khurram Shehzad Kazmi, Mehrin Farooq, Iqra Iftikhar, Naqsh Fatima, Mahwish Shahzad, Asad Ullah Ijaz, Humna Khalid
OBJECTIVE: The study aimed to study the association of hypomagnesemia with diabetic complications in type 2 diabetics. MATERIALS AND METHOD: This cross-sectional study, conducted at a Ghurki Trust Teaching Hospital, spanned from January to June 2023 and included 100 randomly selected diabetic patients aged 30-70. With institutional board approval and informed consent, the study focused on assessing hypomagnesemia, using a standard level of below 1.6 mg/dL, ensuring participant confidentiality and privacy...
March 2024: Curēus
https://read.qxmd.com/read/38645437/molecular-mechanism-and-intervention-measures-of-microvascular-complications-in-diabetes
#5
REVIEW
Rui Xu, Ziming Fang, Hongyu Wang, Ye Gu, Liying Yu, Boyang Zhang, Jingyu Xu
OBJECTIVE: In this article, the epidemiology, molecular mechanism of occurrence and development, risk factors, and treatment of diabetic microvascular complications such as diabetic nephropathy, diabetic retinopathy, and diabetic peripheral neuropathy were discussed, providing the theoretical basis for more accurate elucidation of the pathogenesis and treatment of diabetic microvascular complications. METHODS: The electronic database of PubMed was searched, and retrieved papers were screened for eligibility by two independent reviewers...
2024: Open Medicine (Warsaw, Poland)
https://read.qxmd.com/read/38644711/alpha-lipoic-acid-an-antioxidant-with-anti-aging-properties-for-disease-therapy
#6
JOURNAL ARTICLE
Mariia Shanaida, Roman Lysiuk, Olha Mykhailenko, Nataliia Hudz, Abdullateef Abdulsalam, Tetiana Gontova, Oleksandra Oleshchuk, Yana Ivankiv, Volodymyr Shanaida, Dmytro Lytkin, Geir Bjørklund
The anti-aging effects of alpha-lipoic acid (αLA), a natural antioxidant synthesized in human tissues, have attracted a growing interest in recent years. αLA is a short- -chain sulfur-containing fatty acid occurring in the mitochondria of all kinds of eukaryotic cells. Both the oxidized disulfide of αLA and its reduced form (dihydrolipoic acid, DHLA) exhibit prominent antioxidant function. The amount of αLA inside the human body gradually decreases with age resulting in various health disorders...
April 19, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38642691/ganoderma-lucidum-multifaceted-mechanisms-to-combat-diabetes-through-polysaccharides-and-triterpenoids-a-comprehensive-review
#7
REVIEW
Md Faruque Ahmad, Fakhruddin Ali Ahmad, Nazim Hasan, Abdulrahman A Alsayegh, Othman Hakami, Farkad Bantun, Shadma Tasneem, Waleed M Alamie, Ahmad O Babalghith, Abdullah F Aldairi, Nahla Kambal, Ehab Y Elbendary
Diabetes is a chronic metabolic disorder. Diabetes complications can affect many organs and systems in the body. Ganoderma lucidum (G. lucidum) contains various compounds that have been studied for their potential antidiabetic effects, including polysaccharides, triterpenoids (ganoderic acids, ganoderol B), proteoglycans, and G. lucidum extracts. G. lucidum polysaccharides (GLPs) and triterpenoids have been shown to act through distinct mechanisms, such as improving glucose metabolism, modulating the mitogen-activated protein kinase (MAPK) system, inhibiting the nuclear factor-kappa B (NF-κB) pathway, and protecting the pancreatic beta cells...
April 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38642631/inhibition-of-hdac6-with-cay10603-alleviates-acute-and-chronic-kidney-injury-by-suppressing-the-atf6-branch-of-upr
#8
JOURNAL ARTICLE
Shuyan Kan, Qing Hou, Ruixiang Yang, Fan Yang, Mingchao Zhang, Zhihong Liu, Song Jiang
BACKGROUND: histone deacetylase 6 (HDAC6) inhibitor CAY10603 has been identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD). The objective of this study was to investigate the therapeutic effects of CAY10603 in mice with acute kidney injury (AKI) and chronic kidney diseases (CKD). METHODS: Renal immunohistology was performed to assess expression level of HDAC6 in both human and mouse kidney samples. C57BL/6J mice were intraperitoneal injected with lipopolysaccharide (LPS) to induce AKI; CD-1 mice were fed with adenine diet to induce adenine-nephropathy as CKD model...
April 18, 2024: Archives of Biochemistry and Biophysics
https://read.qxmd.com/read/38641797/diabetic-kidney-disease-screening-status-and-related-factors-a-cross-sectional-study-of-patients-with-type-2-diabetes-in-six-provinces-in-china
#9
JOURNAL ARTICLE
Zhang Xia, Xuechun Luo, Yanzhi Wang, Tingling Xu, Jianqun Dong, Wei Jiang, Yingying Jiang
OBJECTIVE: To understand the awareness and practice of diabetic kidney disease (DKD) or nephropathy screening among community-based patients with type 2 diabetes in six provinces and cities in China, and to analyse the related factors affecting screening practices. METHODS: From December 2021 to March 2022, a cross-sectional survey was conducted using a structured questionnaire in 6230 patients with type 2 diabetes aged 18 years and older. The content of the questionnaire includes three parts: the general situation of diabetic patients (gender, age, ethnicity, marriage, education, occupation, etc...
April 19, 2024: BMC Health Services Research
https://read.qxmd.com/read/38640098/spilanthes-filicaulis-schumach-thonn-c-d-adams-leaves-protects-against-streptozotocin-induced-diabetic-nephropathy
#10
JOURNAL ARTICLE
Oluwafemi Adeleke Ojo, Akingbolabo Daniel Ogunlakin, Christopher Oloruntoba Akintayo, Olaoluwa Sesan Olukiran, Juliana Bunmi Adetunji, Omolola Adenike Ajayi-Odoko, Theophilus Oghenenyoreme Ogwa, Olorunfemi Raphael Molehin, Omolara Olajumoke Ojo, Ramzi A Mothana, Abdullah R Alanzi
BACKGROUND AND OBJECTIVE: Diabetic neuropathy (DN) is a complex type of diabetes. The underlying cause of diabetic nephropathy remains unclear and may be due to a variety of pathological conditions resulting in kidney failure. This study examines the protective effect of the methanolic extract of Spilanthes filicaulis leaves (MESFL) in fructose-fed streptozotocin (STZ)-induced diabetic nephropathy and the associated pathway. METHODS: Twenty-five rats were equally divided randomly into five categories: Control (C), diabetic control, diabetic + metformin (100 mg/kg), diabetic + MESFL 150 mg/kg bw, and diabetic + MESFL 300 mg/kg bw...
2024: PloS One
https://read.qxmd.com/read/38638136/risk-factors-for-erectile-dysfunction-in-diabetes-mellitus-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Diliyaer Dilixiati, Alapati Waili, Aizihaier Tuerxunmaimaiti, Liwen Tao, Abudureheman Zebibula, Mulati Rexiati
BACKGROUND: Previous studies have established that diabetes mellitus (DM) markedly raises the risk of developing erectile dysfunction (ED). Despite extensive investigations, the risk factors associated with ED in diabetic men have yet to be unequivocally determined, owing to incongruent and inconclusive results reported in various studies. OBJECTIVE: The objective of this systematic review and meta-analysis was to assess the risk factors for ED in men with DM. METHODS: A comprehensive systematic review was conducted, encompassing studies published in the PubMed, Scopus and Embase databases up to August 24th, 2023...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38636575/chinese-herbal-medicine-for-the-treatment-of-diabetic-nephropathy-from-clinical-evidence-to-potential-mechanisms
#12
REVIEW
Xiao-Xiao Gong, Lin-Hai Cao, Hong-Xia Ni, Zi-Yan Zang, Hui Chang
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic nephropathy (DN) is a typical chronic microvascular complication of diabetes, characterized by proteinuria and a gradual decline in renal function. At present, there are limited clinical interventions aimed at preventing the progression of DN to end-stage renal disease (ESRD). However, Chinese herbal medicine presents a distinct therapeutic approach that can be effectively combined with conventional Western medicine treatments to safeguard renal function...
April 16, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38635872/fucoidan-improves-early-stage-diabetic-nephropathy-via-the-gut-microbiota-mitochondria-axis-in-high-fat-diet-induced-diabetic-mice
#13
JOURNAL ARTICLE
Zhaoyi Zhong, Yangting Zhang, Yuan Wei, Xiaona Li, Lisheng Ren, Yan Li, Xueqian Zhang, Chengyu Chen, Xueru Yin, Run Liu, Qiuzhen Wang
Diabetic nephropathy (DN) is a common microvascular complication of diabetes. Fucoidan, a polysaccharide containing fucose and sulfate group, ameliorates DN. However, the underlying mechanism has not been fully understood. This study aimed to explore the effects and mechanism of fucoidan on DN in high-fat diet-induced diabetic mice. A total of 90 C57BL/6J mice were randomly assigned to six groups ( n = 15) as follows: normal control (NC), diabetes mellitus (DM), metformin (MTF), low-dose fucoidan (LFC), medium-dose fucoidan (MFC), and high-dose fucoidan (HFC)...
April 18, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38635562/epidemiology-and-referral-patterns-of-patients-living-with-chronic-kidney-disease-in-johannesburg-south-africa-a-single-centre-experience
#14
JOURNAL ARTICLE
Yusuf Urade, Zaheera Cassimjee, Chandni Dayal, Sheetal Chiba, Adekunle Ajayi, Malcolm Davies
Chronic kidney disease (CKD) is a significant contributor to the global burden of non-communicable disease. Early intervention may facilitate slowing down of progression of CKD; recognition of at-risk patient groups may improve detection through screening. We retrospectively reviewed the clinical records of 960 patients attending a specialist nephrology outpatient clinic during the period 1 January 2011-31 December 2021. A significant proportion (47.8%) of patients were referred with established CKD stage G4 or G5...
2024: PLOS Glob Public Health
https://read.qxmd.com/read/38632038/long-term-exposure-to-ambient-air-pollution-and-risk-of-microvascular-complications-among-patients-with-type-2-diabetes-a-prospective-study
#15
JOURNAL ARTICLE
Bin Wang, Ying Sun, Kun Zhang, Yuying Wang, Xiao Tan, Ningjian Wang, Yingli Lu
BACKGROUND: Patients with type 2 diabetes (T2D) may disproportionately suffer the adverse cardiovascular effects of air pollution, but relevant evidence on microvascular outcome is lacking. We aimed to examine the association between air pollution exposure and the risk of microvascular complications among patients with T2D. METHODS: This prospective study included 17 995 participants with T2D who were free of macro- and micro-vascular complications at baseline from the UK Biobank...
April 11, 2024: International Journal of Epidemiology
https://read.qxmd.com/read/38630340/alect2-amyloidosis-with-concurrent-igg4-related-interstitial-nephritis-membranous-nephropathy-and-diabetic-kidney-disease-a-case-report-and-literature-review
#16
JOURNAL ARTICLE
Muhammad Shaheen, Anchit Bharat, Allon N Friedman, Shunhua Guo
Leukocyte chemotactic factor-2 amyloidosis (ALECT2) is a recently described subtype of amyloidosis. IgG4-related disease is a rare fibroinflammatory condition characterized by dense interstitial lymphoplasmacytic infiltrates and fibrosis. Membranous nephropathy and diabetic nephropathy are common causes of nephrotic syndrome. Here we report a 49-year-old Hispanic male patient with diabetes mellitus who presented with jaundice and pruritus. IgG4-related autoimmune pancreatitis was diagnosed through laboratory workup and ampulla biopsy...
April 17, 2024: Journal of Nephrology
https://read.qxmd.com/read/38629025/jiawei-shengjiangsan-s-effect-on-renal-injury-in-diabetic-nephropathy-mice-is-investigated-via-the-pi3k-akt-nf-%C3%AE%C2%BAb-signaling-pathway
#17
JOURNAL ARTICLE
Chenhua Yang, Fengling Huang, Huiqin Fang, Yunhua Zang
PURPOSE: This study aimed to investigate the intervention mechanism of Jiawei Shengjiangsan (JWSJS) on kidney injury in diabetic nephropathy mice. METHODS: Thirty 8-week-old db/db mice were randomly divided into five groups: model group, Perindopril group, and JWSJS low-, medium-, and high-dose groups (n=6 per group) based on body weight. Additionally, a blank control group was established consisting of 6 db/m mice aged 8 weeks. The blank and model groups received daily intragastric administration of 7g/kg/d pure water...
2024: Diabetes, Metabolic Syndrome and Obesity
https://read.qxmd.com/read/38628623/correlation-between-c4-igg-with-macroproteinuria-in-chronic-kidney-disease-a-pilot-study
#18
JOURNAL ARTICLE
Hao Zhang, Anqi Xu, Xiangxiang Li, Binbin Pan, Xin Wan
BACKGROUND AND OBJECTIVES: Loss of immunoglobulin G (IgG) is accompanied with proteinuria, especially macroproteinuria. The complement system participates kidney disease resulting in proteinuria. Whether the ratio of complement and IgG is associated with macroproteinuria remains unknown. DESIGN SETTING PARTICIPANTS AND MEASUREMENTS: A total of 1013 non-dialysis chronic kidney disease (CKD) patients were recruited according to the electrical case records system with 268 patients who endured kidney biopsy...
2024: ImmunoTargets and Therapy
https://read.qxmd.com/read/38626544/dipeptidase-1-promotes-ferroptosis-in-renal-tubular-epithelial-cells-in-diabetic-nephropathy-via-inhibition-of-the-gsh-gpx4-axis
#19
JOURNAL ARTICLE
Yan Li, Xueqi Wang, Qidong Zhang, Dongli Tian, Yu Bai, Yiduo Feng, Wenhu Liu, Zongli Diao
Renal tubular injury is an important pathological change associated with diabetic nephropathy (DN), in which ferroptosis of renal tubular epithelial cells is critical to its pathogenesis. Inhibition of the glutathione/glutathione peroxidase 4 (GSH/GPX4) axis is the most important mechanism in DN tubular epithelial cell ferroptosis, but the underlying reason for this is unclear. Our biogenic analysis showed that a zinc-dependent metalloproteinase, dipeptidase 1 (DPEP1), is associated with DN ferroptosis. Here, we investigated the role and mechanism of DPEP1 in DN tubular epithelial cell ferroptosis...
April 15, 2024: International Immunopharmacology
https://read.qxmd.com/read/38625739/the-secreted-micropeptide-c4orf48-enhances-renal-fibrosis-via-an-rna-binding-mechanism
#20
JOURNAL ARTICLE
Jiayi Yang, Hongjie Zhuang, Jinhua Li, Ana B Nunez-Nescolarde, Ning Luo, Huiting Chen, Andy Li, Xinli Qu, Qing Wang, Jinjin Fan, Xiaoyan Bai, Zhiming Ye, Bing Gu, Yue Meng, Xingyuan Zhang, Di Wu, Youyang Sia, Xiaoyun Jiang, Wei Chen, Alexander N Combes, David J Nikolic-Paterson, Xueqing Yu
Renal interstitial fibrosis is an important mechanism in the progression of chronic kidney disease (CKD) to end-stage kidney disease. However, we lack specific treatments to slow or halt renal fibrosis. Ribosome profiling identified upregulation of a secreted micropeptide, C4orf48 (Cf48), in mouse diabetic nephropathy. Cf48 RNA and protein levels were upregulated in tubular epithelial cells in human and experimental CKD. Serum Cf48 levels were increased in human CKD and correlated with loss of kidney function, increasing CKD stage, and the degree of active interstitial fibrosis...
April 16, 2024: Journal of Clinical Investigation
keyword
keyword
59378
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.